VERDOT Opens New Manufacturing Facility in France
News related to:VERDOT · 2 min read
VERDOT, a specialist in purification technologies for the biopharmaceutical industry, has unveiled its new Centre of Excellence and manufacturing facility in Saint-Beauzire, France. The new site, located within the Biopôle Clermont-Limagne life sciences technology park, is designed to enhance the company's production capacity and support more sustainable operations.
The new 4,200 square meter facility is expected to increase manufacturing capacity by 150%, allowing VERDOT to produce chromatography systems, tangential flow filtration systems, chromatography columns, and tailor-made downstream purification equipment for biopharmaceutical customers. This expansion is part of the company's strategic plan to better serve its global customer base and strengthen its position as a leading provider of purification solutions.
VERDOT's new site is not only a testament to the company's commitment to growth but also to its dedication to sustainability. The facility incorporates various eco-friendly features, including photovoltaic panels, green roofing, rainwater recovery and reuse systems, and electric vehicle charging stations. These sustainable measures align with VERDOT's long-term objective of reducing its environmental impact and contributing to more sustainable bioprocessing.
Charles Ruban, President and CEO of VERDOT, stated, "This new site gives VERDOT the industrial scale and technical environment needed for the next stage of our development. It strengthens what we do best: designing and manufacturing high-performance downstream purification solutions in France for biopharmaceutical customers around the world."
The Saint-Beauzire site reinforces VERDOT's position as a French industrial player while supporting its international customers. From this location, the company will continue to develop and manufacture downstream purification technologies used by biotech companies, biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and research organizations across major global biomanufacturing markets.
This designation underscores VERDOT's commitment to contributing to the country's healthcare sector and its role in advancing bioprocessing technologies.
The new facility will also serve as a hub for industrial know-how, engineering expertise, and innovation in downstream bioprocessing. It will bring together production, engineering, research and development, and applications teams, improving operational efficiency and enabling faster execution of both standard and custom projects.
VERDOT stands at the forefront of downstream bioprocessing technology, offering innovative single-use and stainless steel purification solutions for the biopharmaceutical industry. The company's solutions range from standard to highly customized designs, enabling customers to accelerate the time-to-market of groundbreaking therapies. With its new facility, VERDOT is well-positioned to continue driving innovation and meeting the evolving needs of the biopharmaceutical industry.